Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -3.64%14 3-1 Month Momentum % is -61.56% as of Sep. 09, 2026. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 667 Healthcare Providers & Services companies, NewGenIvf Group ranks worse than 98.8% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-09), NewGenIvf Group's 3-1 Month Momentum % is -61.56%.
The industry rank for NewGenIvf Group's 3-1 Month Momentum % or its related term are showing as below:
NIVF's 3-1 Month Momentum % is ranked worse than 98.8% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 1.74
vs NIVF: -61.56
NewGenIvf Group (NAS:NIVF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
NewGenIvf Group 3-1 Month Momentum % Related Terms
NIVF vs CDIX, RHEP, PAIYY: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's 3-1 Month Momentum % falls into.
NewGenIvf Group (NAS:NIVF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group (NIVF) has a 3-1 Month Momentum % of -61.56% as of Sep. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on NewGenIvf Group and its competitors. According to the industry distribution chart, NewGenIvf Group ranks #659 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 98.8%.
Is NewGenIvf Group's 3-1 Month Momentum % too high?
NewGenIvf Group's current 3-1 Month Momentum % is -61.56%. Based on the distribution chart, NewGenIvf Group ranks #659 out of 667 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's 3-1 Month Momentum % compare to CDIX and RHEP?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #659 out of 667 companies for 3-1 Month Momentum %. This places NewGenIvf Group in the lower half of its industry. The industry median 3-1 Month Momentum % is 1.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 1.74, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on NewGenIvf Group and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 1.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current 3-1 Month Momentum % is -61.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current 3-1 Month Momentum % of -61.56%. The current 3-1 Month Momentum % is -61.56%. NewGenIvf Group's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current 3-1 Month Momentum % is -61.56% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
